tiprankstipranks
Advertisement
Advertisement

OBIO Stock Latest News

Orchestra granted additional breakthrough device designation for AVIM therapy
The FlyOrchestra granted additional breakthrough device designation for AVIM therapy
2d ago
MDT
OBIO
Orchestra BioMed: Accelerating Pivotal Trials and Strengthened Liquidity Support Buy Rating and Long‑Term Growth Outlook
PremiumRatings
Orchestra BioMed: Accelerating Pivotal Trials and Strengthened Liquidity Support Buy Rating and Long‑Term Growth Outlook
2M ago
OBIO
Midday Fly By: Dick’s Sporting, Dollar General report quarterly beats
PremiumThe Fly
Midday Fly By: Dick’s Sporting, Dollar General report quarterly beats
2M ago
BP
CI
Orchestra BioMed reports FY25 EPS ($1.11), consensus ($1.74)
PremiumThe Fly
Orchestra BioMed reports FY25 EPS ($1.11), consensus ($1.74)
2M ago
OBIO
Orchestra BioMed: Undervalued Cardiovascular Innovator Poised for Multi‑Year Catalyst Cycle
PremiumRatings
Orchestra BioMed: Undervalued Cardiovascular Innovator Poised for Multi‑Year Catalyst Cycle
2M ago
OBIO
Orchestra BioMed management to meet with B. Riley
PremiumThe FlyOrchestra BioMed management to meet with B. Riley
2M ago
OBIO
Orchestra BioMed announces two presentations at THT, CRT 2026 meetings
Premium
The Fly
Orchestra BioMed announces two presentations at THT, CRT 2026 meetings
2M ago
OBIO
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan
Premium
Company Announcements
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan
3M ago
8K
OBIO
Orchestra BioMed gains cash from Vivasure sale proceeds
PremiumCompany Announcements
Orchestra BioMed gains cash from Vivasure sale proceeds
4M ago
8K
OBIO
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
PremiumThe Fly
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
4M ago
HAE
OBIO
Orchestra BioMed price target raised to $12 from $11 at Barclays
PremiumThe Fly
Orchestra BioMed price target raised to $12 from $11 at Barclays
4M ago
OBIO
Orchestra BioMed initiated with a Buy at TD Cowen
PremiumThe Fly
Orchestra BioMed initiated with a Buy at TD Cowen
5M ago
OBIO
Is OBIO a Buy, Before Earnings?
PremiumPre-EarningsIs OBIO a Buy, Before Earnings?
6M ago
OBIO
Orchestra BioMed Secures FDA Breakthrough Designation
Premium
Company Announcements
Orchestra BioMed Secures FDA Breakthrough Designation
6M ago
8K
OBIO
Orchestra BioMed price target lowered to $11 from $12 at Barclays
Premium
The Fly
Orchestra BioMed price target lowered to $11 from $12 at Barclays
6M ago
OBIO
Orchestra BioMed reports Q3 EPS (40c), consensus (43c)
PremiumThe Fly
Orchestra BioMed reports Q3 EPS (40c), consensus (43c)
6M ago
OBIO
Orchestra BioMed files to sell 8.03M shares of common stock for holders
PremiumThe Fly
Orchestra BioMed files to sell 8.03M shares of common stock for holders
6M ago
OBIO
Orchestra BioMed Secures $147M for Therapy Advancements
PremiumCompany Announcements
Orchestra BioMed Secures $147M for Therapy Advancements
6M ago
8K
OBIO
Orchestra BioMed Announces Strategic Agreement with Terumo
PremiumCompany Announcements
Orchestra BioMed Announces Strategic Agreement with Terumo
6M ago
8K
OBIO
Orchestra BioMed, Terumo enter new $30M Virtue SAB agreements
PremiumThe FlyOrchestra BioMed, Terumo enter new $30M Virtue SAB agreements
6M ago
OBIO
Orchestra Biomed’s New Study: A Game Changer in Coronary Treatment?
Premium
Company Announcements
Orchestra Biomed’s New Study: A Game Changer in Coronary Treatment?
6M ago
OBIO
Orchestra BioMed announces first patient enrollments in Virtue SAB
Premium
The Fly
Orchestra BioMed announces first patient enrollments in Virtue SAB
6M ago
OBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >